Pharma and laboratory590439-2026

Croatia – Reagents and contrast media – Reagensi, testovi i potrošni materijal za laboratorijsku dijagnostiku

OŽB NAŠICE

Buyer country

Croatia

Publication date

Not specified

Biderra sector

Pharma and laboratory

Data source

TED open data

Decision signals

First-pass opportunity review

These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.

Timing signal
Deadline not indexed

Check the official notice

Indexed data completeness
100%

Based on seven decision fields

Official title coverage
7 languages

Preserved from source-supplied versions

Classification signal
33696000

Medical equipment, pharmaceuticals and personal care products

Official title versions

TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.

Spanish

Croacia – Reactivos y medios de contraste – Reagensi, testovi i potrošni materijal za laboratorijsku dijagnostiku

Dutch

Kroatië – Reagentia en contraststoffen – Reagensi, testovi i potrošni materijal za laboratorijsku dijagnostiku

Polish

Chorwacja – Odczynniki i środki kontrastowe – Reagensi, testovi i potrošni materijal za laboratorijsku dijagnostiku

French

Croatie – Réactifs et produits de contraste – Reagensi, testovi i potrošni materijal za laboratorijsku dijagnostiku

German

Kroatien – Reagentien und Kontrastmittel – Reagensi, testovi i potrošni materijal za laboratorijsku dijagnostiku

Italian

Croazia – Reagenti e mezzi di contrasto – Reagensi, testovi i potrošni materijal za laboratorijsku dijagnostiku

English

Croatia – Reagents and contrast media – Reagensi, testovi i potrošni materijal za laboratorijsku dijagnostiku

What Biderra adds

For notice 590439-2026, Biderra has normalized the contracting authority country as Croatia, grouped CPV 33696000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.